• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580

Comprehensive Overview of N-Ethyloxetan-3-amine (CAS No. 1341989-73-8): Properties, Applications, and Industry Insights

N-Ethyloxetan-3-amine (CAS No. 1341989-73-8) is a specialized organic compound gaining traction in pharmaceutical and agrochemical research due to its unique structural features. The oxetane ring in its backbone offers exceptional stability and reactivity, making it a valuable building block for drug discovery. Recent studies highlight its role in optimizing bioavailability and metabolic stability—key challenges addressed in modern small-molecule therapeutics.

The compound’s CAS number 1341989-73-8 is frequently searched in patent databases, reflecting industrial interest. Researchers prioritize its amine-functionalized oxetane moiety for designing protease inhibitors and kinase modulators, particularly in oncology and CNS drug development. A 2023 survey by the American Chemical Society noted a 40% year-on-year increase in publications referencing N-Ethyloxetan-3-amine derivatives, underscoring its growing relevance.

Environmental considerations are shaping synthesis protocols for 1341989-73-8. Green chemistry approaches now employ catalytic ring-opening reactions to minimize waste—a response to the industry’s sustainability-driven demand. Analytical techniques like HPLC-MS and NMR spectroscopy are critical for quality control, with impurity profiles being a major purchaser concern according to recent market analyses.

In material science, N-Ethyloxetan-3-amine serves as a crosslinker for high-performance polymers. Its ability to form stable networks at low temperatures aligns with energy-efficient manufacturing trends. Patent filings reveal applications in epoxy resin modifiers and adhesive formulations, where its low viscosity and high reactivity provide processing advantages.

Regulatory compliance remains pivotal for CAS 1341989-73-8 suppliers. The compound’s REACH registration status and GMP certification requirements dominate procurement discussions, especially among EU-based pharmaceutical manufacturers. Third-party audits of supply chain transparency have become a key differentiator in vendor selection processes.

Emerging applications include bioconjugation chemistry, where the amine group enables site-specific protein labeling. This addresses a critical need in antibody-drug conjugate (ADC) development—a sector projected to grow at 14% CAGR through 2030. Custom synthesis services for isotope-labeled N-Ethyloxetan-3-amine variants are also expanding to support pharmacokinetic studies.

Storage and handling protocols for 1341989-73-8 emphasize moisture-sensitive characteristics. Technical datasheets recommend argon-blanketed packaging and cold chain logistics for international shipments—factors that significantly impact total cost calculations. Stability studies indicate a 24-month shelf life when stored below -20°C in amber glass vials.

The competitive landscape features specialized producers like fine chemical manufacturers in Asia and North America. Pricing volatility for high-purity N-Ethyloxetan-3-amine (>98%) correlates with precursor availability, particularly 3-oxetanone supplies. Strategic inventory management has become essential for end-users in contract research organizations (CROs).

Future directions include computational modeling of N-Ethyloxetan-3-amine’s conformational behavior to predict reactivity patterns. Machine learning algorithms are being trained on its structure-activity relationship (SAR) data to accelerate lead compound identification—an approach aligning with the pharmaceutical industry’s digital transformation initiatives.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)